A few hours ago, anti-malware software provider Malwarebytes announced that it had completed the acquisition of ZeroVulnerabilityLabs Inc., a company that specializes in vulnerability, exploit and security research.
The acquisition will enable Malwarebytes to expand its anti-malware suite.
“I am very pleased to announce the acquisition of ZeroVulnerabilityLabs and to welcome its employees to the Malwarebytes team,” noted Malwarebytes CEO, Marcin Kleczynski.
“We are always looking to improve upon our existing offerings, and have done so with the addition of ZeroVulnerabilityLabs’ technology. The proactive nature of this technology makes it a great addition and compliment to the existing Malwarebytes software suite.”
“We are excited to be joining the Malwarebytes team and to work to advance the latest anti-exploit R & D efforts, which we started at ZeroVulnerabilityLabs,” commented Pedro Bustamante, co-founder and CEO of ZeroVulnerabilityLabs.
“It is a great fit between two companies who are fighting malware in innovative and effective ways in order to protect both users and companies from the most dangerous and complex types of attacks.”
ZeroVulnerabilityLabs’ flagship product, ExploitShield, has been rebranded as a Malwarebytes product and named Malwarebytes Anti-Exploit. A beta version of the product is available for a limited time on zerovulnerabilitylabs.com.